Related Experiment Video
Updated: Aug 9, 2026

A Contrast of Three Inoculation Techniques used to Determine the Race of Unknown Fusarium oxysporum f.sp. niveum Isolates
Published on: October 28, 2021
Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility
Marcela de Souza1, Tetsuhiro Matsuzawa2, Luzia Lyra3
1Department of Internal Medicine, School of Medicine, University of Campinas, Campinas, São Paulo Brazil ; LIM 46 - Laboratory of Parasitology - HC/FMUSP, Kragujevac, São Paulo Brazil.
Introduction:
During the last decades, Fusarium spp. has been reported as a significant cause of disease in humans, especially in immunocompromised patients, who have high risk of invasive life-threatening disease. Fusarium species usually reported as cause of human disease are F. solani, F. oxysporum and F. verticillioides.
Case Description:
We describe the second case in the literature of disseminated fusariosis caused by Fusarium napiforme, that occurred in a 60-year-old woman with multiple myeloma after subsequent cycles of chemotherapy.
Discussion And Evaluation:
We identified the F. napiforme not only by standard morphologic criteria by macroscopic and microscopic characteristics, but also confirmed by molecular biology methods, including sequencing. The antifungal susceptibility of the F. napiforme isolates were tested to seven antifungal drugs; the azoles were the most active drug against all the isolates tested.
Conclusions:
Fusarium spp. are of relevance in medical mycology, and their profiles of low susceptibility to antifungal drugs highlight the importance for faster and more accurate diagnostic tests, what can contribute to an earlier and precise diagnosis and treatment.
Insights
Disseminated fusariosis caused by Fusarium napiforme is rare, particularly in immunocompromised patients. This case highlights the need for rapid diagnostics and effective antifungal treatments for invasive Fusarium infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Case Study
Background:
- Fusarium species are increasingly recognized as significant pathogens in humans, especially immunocompromised individuals.
- Invasive, life-threatening infections caused by Fusarium spp. pose a considerable risk.
- Commonly implicated species include Fusarium solani, Fusarium oxysporum, and Fusarium verticillioides.
Purpose of the Study:
- To report the second documented case of disseminated fusariosis caused by Fusarium napiforme.
- To detail the clinical presentation and diagnostic findings in a patient with multiple myeloma undergoing chemotherapy.
- To evaluate the antifungal susceptibility profile of the isolated Fusarium napiforme.
Main Methods:
- Morphological identification (macroscopic and microscopic) of Fusarium napiforme.
- Molecular methods, including sequencing, for definitive species identification.
- Antifungal susceptibility testing against seven antifungal drugs.
Main Results:
- The patient, a 60-year-old woman with multiple myeloma, developed disseminated fusariosis after chemotherapy.
- Fusarium napiforme was identified using both traditional and molecular techniques.
- Azoles demonstrated the highest in vitro activity against the F. napiforme isolates.
Conclusions:
- Fusarium species are clinically relevant fungal pathogens.
- The observed low susceptibility to certain antifungal drugs underscores the need for improved diagnostic methods.
- Faster and more accurate diagnostics are crucial for timely and effective treatment of invasive fusariosis.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Candidiasis
Antifungal Agents

